Stock Taper 
| DATE | TYPE | RATIO |
|---|---|---|
| 2018-09-05 | Reverse | 1:15 |
| 2016-11-29 | Reverse | 1:9 |
| 2016-05-09 | Reverse | 1:12 |
| 2011-07-06 | Reverse | 1:10 |
Microbot Medical Inc. develops robotic endoluminal devices for minimally invasive surgery, including treatments for hydrocephalus and endovascular procedures, with patented technologies and a collaboration with Stryker.
The LIBERTY® Endovascular Robotic System, FDA-cleared and single-use, enables remote, precise navigation of vascular tools, reducing radiation and strain, with full market launch planned for April 2026 by Microbot Medical.
Microbot Medical Inc. received FDA 510(k) clearance for its LIBERTY® Endovascular Robotic System, making it the first single-use, remotely operated robotic system for peripheral endovascular procedures to be approved in the U.S. This pivotal regulatory milestone was the catalyst for the company's transition to a commercial-stage entity and garnered significant attention from investors and the media. Following the announcement, the company's stock experienced a substantial rally, marking a defining moment for Microbot in 2025.
Following FDA 510(k) clearance in September 2025, Microbot Medical initiated a limited market release of its flagship product, the LIBERTY® Endovascular Robotic System, in the fourth quarter of 2025. This marks a pivotal transition for the company from a clinical-stage to a commercial-stage entity, with the first adoption by Emory University Hospital.
Medtechnica Ltd., a Leading Medical Device Distributor in Israel, Authorized to Distribute the LIBERTY® Endovascular Robotic System Throughout Israel Microbot Medical is Executing its International Markets Strategy by Engaging with Distributors in Developed Markets to Prepare for Potential Future Market Entry Outside of the U.S. HINGHAM, Mass.
Overall rating: C
| PEER | PRICE | |
|---|---|---|
 OVID | $2.35 | COMPARE |
 RCEL | $13.03 | COMPARE |
 ORMP | $4.21 | COMPARE |
 CRDL | $1.29 | COMPARE |
 VANI | $1.20 | COMPARE |
 CLNN | $3.83 | COMPARE |
 DCGO | $0.34 | COMPARE |
 CNTX | $0.31 | COMPARE |
